Axol Introduces Steve Rees as Scientific Advisory Board Member Thursday, January 21, 2016 The stem cell disease model specialists also showcase expanded range of primary and iPSC-derived cells for drug discovery.Protagen AG Joins RA-MAP Consortium Thursday, January 21, 2016 Protagen AG, a company concerned with the development of advanced diagnostic tools to address some of the most severe autoimmune diseases, has announced that it will join the RA-MAP Consortium. Novozymes Forms Albumedix Wednesday, January 20, 2016 The new stand-alone company Albumedix will continue to develop albumin-based products and technologies for the pharmaceutical industry.Seeing Hope Wednesday, January 20, 2016 Gene therapy/drug combo restores some vision in mice with optic nerve injury.Centauri Acquires Alphamer Wednesday, January 20, 2016 Centauri Therapeutics Ltd, a biotechnology company focused on the treatment of infectious diseases, has announced that it has acquired the Alphamer technology for drug discovery and development from Altermune Technologies LLC. Amarantus to Merge Diagnostics Unit with Avant Wednesday, January 20, 2016 Amarantus Bioscience Holdings and Avant Diagnostics have announced they have entered into a Letter of Intent (the "LOI") to merge an Amarantus wholly-owned subsidiary, Amarantus Diagnostics, into Avant Diagnostics. BioAscent, Pierre Fabre Collaborate Wednesday, January 20, 2016 Pharma and cosmetics multinational selects BioAscent as central hub for storage and logistics of extensive plant natural extracts collection.Pall, Kaneka Enter Agreement Wednesday, January 20, 2016 Pall Corporation announced the signing of a supply agreement for KANEKA KanCapA Japan for the primary capture of monoclonal antibodies from clarified cell culture. Versatile New Molecule-Building Technique Tuesday, January 19, 2016 Chemists at The Scripps Research Institute (TSRI) have devised a new and widely applicable technique for building potential drug molecules and other organic compounds.